2 August 2013
Further to the announcement made on 31 May 2013 about a preliminary approach for the Medical division, Smiths Group announces that it has not proved possible to reach agreement with the potential counterparty on acceptable terms for a transaction. Discussions have therefore been terminated.
In reaching this conclusion, the Board has taken full account of the quality and highly cash generative nature of Smiths Medical, both standalone and in the context of the Group as a whole.
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Strategic actions to unlock significant value and enhance returns to shareholders
Find out more
Cyber Security Incident
Find out more
Smiths Detection lightweight chemical detectors (LCD) selected by Japan Ministry of Defence
Find out more
